Compounds > irinotecan
Page last updated: 2024-08-24

irinotecan and Thyroid Neoplasms

irinotecan has been researched along with Thyroid Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, T; Hakoshima, M; Hattori, Y; Koga, K; Komori, M; Maitani, Y; Narishima, R; Yamasaki, M1
Iwase, Y; Maitani, Y3
Briasoulis, E; Karavasilis, V; Pavlidis, N; Rontogianni, D1
Ball, DW; Denmeade, SR; Nelkin, BD; Park, JI; Rosen, DM; Ruggeri, B; Strock, CJ1
Barber, SE; Bekele, BN; Jasser, SA; Kim, S; Mandal, M; Myers, JN; Yazici, YD1
Bekele, BN; Jasser, SA; Kim, S; Myers, JN; Prichard, CN; Yazici, YD; Younes, MN1
Hotta, K; Ichimura, K; Kiura, K; Matsuoka, J; Osawa, M; Tabata, M; Takigawa, N; Tanimoto, M1

Other Studies

9 other study(ies) available for irinotecan and Thyroid Neoplasms

ArticleYear
Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.
    Cancer science, 2010, Volume: 101, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Medullary; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Irinotecan; Mice; Mice, Inbred ICR; Mice, Nude; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; RNA, Small Interfering; Thyroid Neoplasms; Xenograft Model Antitumor Assays

2010
Octreotide-targeted liposomes loaded with CPT-11 enhanced cytotoxicity for the treatment of medullary thyroid carcinoma.
    Molecular pharmaceutics, 2011, Apr-04, Volume: 8, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Camptothecin; Carcinoma, Neuroendocrine; Cell Proliferation; Drug Carriers; Female; Flow Cytometry; Gastrointestinal Agents; Humans; Irinotecan; Liposomes; Mice; Mice, Inbred ICR; Mice, Nude; Octreotide; Receptors, Somatostatin; Thyroid Neoplasms; Tumor Cells, Cultured

2011
Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts.
    Cancer science, 2012, Volume: 103, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Neuroendocrine; Cell Line, Tumor; Humans; Irinotecan; Liposomes; Mice; Octreotide; Phosphorylation; Receptors, Somatostatin; Ribosomal Protein S6 Kinases, 70-kDa; Thyroid Neoplasms; Xenograft Model Antitumor Assays

2012
Preparation and in vivo evaluation of liposomal everolimus for lung carcinoma and thyroid carcinoma.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:6

    Topics: Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cell Line, Tumor; Cell Survival; Everolimus; Female; Humans; Immunosuppressive Agents; Irinotecan; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Sirolimus; Thyroid Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2012
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Irinotecan; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Thyroid Neoplasms

2005
Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Camptothecin; Carbazoles; Carcinoma, Medullary; cdc25 Phosphatases; Cell Cycle; Cell Division; Cell Line, Tumor; Checkpoint Kinase 1; Enzyme Inhibitors; Histones; Humans; Irinotecan; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinases; Protein-Tyrosine Kinases; S Phase; Signal Transduction; Thyroid Neoplasms; Transplantation, Heterologous

2006
Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
    Head & neck, 2006, Volume: 28, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Thyroid Neoplasms

2006
Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jan-15, Volume: 12, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma; Cell Adhesion; Cell Proliferation; Cetuximab; Drug Interactions; Drug Synergism; Humans; Irinotecan; Lymphatic Metastasis; Male; Mice; Mice, Nude; Survival Rate; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

2006
Isolated metastasis of lung cancer to the thyroid gland.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 58, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Small Cell; CD56 Antigen; Chemotherapy, Adjuvant; Chromogranin A; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Irinotecan; Lung Neoplasms; Male; Thyroid Neoplasms

2007